CHINOOK THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Chinook Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2023.
  • Chinook Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $42.9M, a 18% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $42.9M -$9.4M -18% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $47.3M -$6.58M -12.2% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $49M -$6.42M -11.6% Dec 31, 2022 10-Q 2023-08-07
Q3 2022 $50.5M -$6.4M -11.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $52.3M -$880K -1.66% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $53.9M -$498K -0.92% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $55.4M -$288K -0.52% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $56.9M +$36.8M +182% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $53.2M +$32.8M +161% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $54.4M +$33.7M +163% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $55.7M +$53.8M +2861% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $20.2M -$1.18M -5.55% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $20.3M -$1.28M -5.9% Jun 30, 2020 10-Q 2020-08-03
Q1 2020 $20.7M -$1.11M -5.07% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $1.88M Dec 31, 2019 10-K 2021-04-07
Q3 2019 $21.3M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $21.6M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $21.8M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.